Senior Vice President of Supply Chain of Curation Foods and Vice President of Landec · Lifecore Biomedical, Inc. (LFCR)

Timothy Burgess

FY2020 is the first fiscal year CompBrief holds for Timothy Burgess as a named executive officer of Lifecore Biomedical; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$577,853

Salary $323,750Stock awards $190,225

4th of 6 named executive officers at Lifecore Biomedical by FY2020 total.

6 named officers on file for Lifecore Biomedical, FY2020

Timothy Burgess’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 1 equity grant, each cited to its filing
  • LFCR’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Lifecore Biomedical’s whole pay program stands against its peers

  • Lifecore Biomedical’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on LFCR→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed August 31, 2020 (DEF 14A).

Free

Get Timothy Burgess’s full pay file as a PDF — free

More than this page: up to 10 years of Timothy’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Timothy Burgess compensation by year

Lifecore Biomedical Summary Compensation Table · the one fiscal year held
In US dollars, as Lifecore Biomedical reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020
Salary$323,750
Bonus$0
Stock awards$190,225
Option awards$0
Non-equity incentive$0
Pension and deferred compensation$0
All other$63,878
Total$577,853

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Lifecore Biomedical, Inc. DEF 14A filed August 31, 2020, accession 0001005286-20-000016, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Lifecore Biomedical, Inc. filed document, accession 0001005286-20-000016. Every figure is read from that document and cited to the page and table it appears in. Filed August 31, 2020.

Equity holdings

unvested awards at FY2020 year-end
TypeUnvested unitsValue at year-endExercise price
RSU17,500$186,725—

Per the Outstanding Equity Awards at Fiscal Year-End table in Lifecore Biomedical, Inc.'s FY2020 proxy; value at the fiscal year-end close, as the company printed it.

Lifecore Biomedical’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
Albert BollesPresident and CEO$980,308
James HallPresident of Lifecore Biomedical and Vice President of Landec$960,196
Gregory SkinnerFormer Executive Vice President of Finance and Administration, Chief Financial Officer$786,481
Timothy Burgess · this pageSenior Vice President of Supply Chain of Curation Foods and Vice President of Landec$577,853
Brian McLaughlinVice President of Finance and Administration, Chief Financial Officer$496,932
Dawn KimballSenior Vice President of Human Resources and Chief People Officer$380,955

The full Lifecore Biomedical compensation record

free company brief

This page is one person within Lifecore Biomedical's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Lifecore Biomedical proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Lifecore Biomedical's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Timothy Burgess's compensation dossier · One-time report. No refunds.